Akebia Therapeutics Inc (AKBA) Reports -19.03% Fall From For 52 Week High, It’s Always Darkest Before The Dawn
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 4.05M shares in volume on a normal day but saw 3158327 shares change hands in the recent trading day. The company now has a market cap of 611.28M USD. Its current market price is $2.34, marking a decrease of -4.49% compared to the previous close of $2.45. The 52 […]
Akebia Therapeutics Inc (NASDAQ: AKBA): Think Like A Lender, Not An Investor
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 3.99M but it saw 2394702 shares traded in last market. With a market cap of 624.34M USD, the company’s current market price of $2.39 came falling about -0.83 while comparing to the previous closing price of $2.41. In past 52 weeks, the stock […]
Predicting Future Price Moves In Akebia Therapeutics Inc (AKBA)
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 3.89M shares in volume on a normal day but saw 2560337 shares change hands in the recent trading day. The company now has a market cap of 634.79M USD. Its current market price is $2.43, marking an increase of 2.10% compared to the previous close of $2.38. The 52 […]
Spotting A Winner: Akebia Therapeutics Inc (NASDAQ: AKBA) Advances 5.56 And It Still Have Room To Run
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 3.91M but it saw 2298836 shares traded in last market. With a market cap of 595.61M USD, the company’s current market price of $2.28 came rising about 5.56 while comparing to the previous closing price of $2.16. In past 52 weeks, the stock […]
Akebia Therapeutics Inc (NASDAQ: AKBA) Gets A 68.15% Target Price Upside From Analysts While 158.75% Above Its 52-Week Low
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 3.93M shares in volume on a normal day but saw 2669501 shares change hands in the recent trading day. The company now has a market cap of 540.75M USD. Its current market price is $2.07, marking an increase of 0.49% compared to the previous close of $2.06. The 52 […]
Akebia Therapeutics Inc (AKBA) Down -34.26% From Its 52-Week High, But Growth Potential Is Changing Over Time
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 3.97M but it saw 3751445 shares traded in last market. With a market cap of 496.34M USD, the company’s current market price of $1.90 came rising about 0.53 while comparing to the previous closing price of $1.89. In past 52 weeks, the stock […]
Predicting Future Price Moves In Akebia Therapeutics Inc (AKBA)
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 3.86M shares in volume on a normal day but saw 4765811 shares change hands in the recent trading day. The company now has a market cap of 431.03M USD. Its current market price is $1.65, marking an increase of 6.45% compared to the previous close of $1.55. The 52 […]
A Few Bright Spots In Akebia Therapeutics Inc (NASDAQ: AKBA)
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 3.72M but it saw 7722515 shares traded in last market. With a market cap of 444.09M USD, the company’s current market price of $1.70 came rising about 1.19 while comparing to the previous closing price of $1.68. In past 52 weeks, the stock […]
Akebia Therapeutics Inc (NASDAQ: AKBA) Gets A 72.77% Target Price Upside From Analysts While 121.25% Above Its 52-Week Low
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 3.57M shares in volume on a normal day but saw 6506652 shares change hands in the recent trading day. The company now has a market cap of 462.38M USD. Its current market price is $1.77, marking a decrease of -5.85% compared to the previous close of $1.88. The 52 […]
Putting The Spotlight On Akebia Therapeutics Inc (AKBA)
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 3.53M but it saw 3193282 shares traded in last market. With a market cap of 504.17M USD, the company’s current market price of $1.93 came rising about 1.05 while comparing to the previous closing price of $1.91. In past 52 weeks, the stock […]
